Use of lanthanum oxyhydroxide in preparation of drug for treating hyperphosphatemia or disease associated with hyperphosphatemia

Abstract

Disclosed is a drug for treating hyperphosphatemia or a disease associated with hyperphosphatemia, including an active ingredient and a pharmaceutically acceptable adjuvant, where the active ingredient includes at least one selected from the group consisting of: a lanthanum oxyhydroxide solvate, lanthanum oxyhydroxide containing a lanthanum isotope and/or an oxygen isotope, and a double salt containing lanthanum oxyhydroxide; or the active ingredient is lanthanum oxyhydroxid, belonging to the field of pharmaceutical technology. The lanthanum oxyhydroxide has a higher lanthanum content reaching 80.8%. Disclosed is also a method for treating hyperphosphatemia or a disease associated with hyperphosphatemia.

Dependencies are inferred from the claim text.